Author

Gunilla Stjernlöf

Observed name: G. Stjernlöf

Institutions: AstraZeneca (United Kingdom), AstraZeneca (Sweden)

Observed institutions: AstraZeneca (United Kingdom), AstraZeneca (Sweden)

OpenAlex ID: A5043971673

Randomised, blinded, cross-over evaluation of the palatability of and preference for different potassium binders in participants with chronic hyperkalaemia in the USA, Canada and Europe: the APPETIZE study

2024 · David C Wheeler, Henning Søndergaard, et al. · BMJ Open · 7

Pos-264 Patient Palatability and Preference Study of 3 Potassium Binders in Patients With Chronic Kidney Disease and Hyperkalaemia: Rationale and Design of the Appetize Study

2021 · G. JAMES, H. Søndergaard, et al. · Kidney International Reports

Patient Palatability and Preference Study of Three Potassium Binders in Patients with CKD and Hyperkalemia: Rationale and Design of the APPETIZE Study

2020 · Glen James, Henning Sϕndergaard, et al. · Journal of the American Society of Nephrology

Works count: 3

Citation count: 7

H-index: 1

I10-index: